Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 3/2020

01-04-2020 | Original Contribution

Effects of dietary glutamine supplementation on immune cell polarization and muscle regeneration in diabetic mice with limb ischemia

Authors: Man-Hui Pai, Cing-Syuan Lei, Shiau-Tsz Su, Sung-Ling Yeh, Yu-Chen Hou

Published in: European Journal of Nutrition | Issue 3/2020

Login to get access

Abstract

Purpose

Diabetes is a chronic inflammatory disorder resulting in endothelial dysfunction which contributes to peripheral arterial disease and limb ischemia. Leukocytes play critical roles in vascular and tissue remodelling after ischemia. This study investigated the effects of dietary glutamine (GLN) supplementation on immune cell polarization in diabetic mice subjected to limb ischemia.

Methods

Diabetes was induced by an intraperitoneal injection of streptozotocin for 5 consecutive days in C57BL/6J mice. Diabetic mice were fed the AIN-93 diet or an AIN-93 diet in which a part of the casein was replaced by GLN. After 3 weeks of the dietary intervention, mice were subjected to unilateral femoral artery ligation to induce limb ischemia.

Results

GLN supplementation enhanced the proportion of anti-inflammatory monocytes and regulatory T cells in the blood. Expression of C-C motif chemokine receptor 5 by activated CD4+ T cells was promoted and prolonged in the GLN-supplemented group. GLN downregulated the percentage of M1 macrophages in muscle tissues which was correlated with lower levels of C-C motif chemokine ligand 2 in plasma. The muscle M1/M2 ratio was also reduced in the GLN group. Gene expression of interleukin-6 was suppressed by GLN supplementation, while expression levels of the peroxisome proliferator-activated receptor γ and myogenic differentiation 1 genes were elevated in post-ischemic muscles. Histological findings also indicated that muscle regeneration was accelerated in the GLN group.

Conclusions

GLN supplementation in diabetic mice may exert more-balanced polarization of CD4+ T cells, monocytes, and macrophages, thus attenuating inflammatory responses and contributing to muscle regeneration after limb ischemia.
Literature
1.
Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS (2015) Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci 16(10):25234–25263CrossRefPubMedPubMedCentral
2.
Spinetti G, Kraenkel N, Emanueli C, Madeddu P (2008) Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res 78(2):265–273CrossRefPubMed
3.
Marso SP, Hiatt WR (2006) Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 47(5):921–929CrossRefPubMed
4.
Kang L, Chen Q, Wang L, Gao L, Meng K, Chen J, Ferro A, Xu B (2009) Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol 36(10):e47–56CrossRefPubMed
5.
Vignaud A, Ramond F, Hourde C, Keller A, Butler-Browne G, Ferry A (2007) Diabetes provides an unfavorable environment for muscle mass and function after muscle injury in mice. Pathobiology 74(5):291–300CrossRefPubMed
6.
Silvestre JS, Smadja DM, Levy BI (2013) Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev 93(4):1743–1802CrossRefPubMed
7.
Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, Munoz-Canoves P (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1(1):21CrossRefPubMedPubMedCentral
8.
Yang J, Zhang L, Yu C, Yang XF, Wang H (2014) Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2(1):1CrossRefPubMedPubMedCentral
9.
10.
Hsieh PL, Rybalko V, Baker AB, Suggs LJ, Farrar RP (2018) Recruitment and therapeutic application of macrophages in skeletal muscles after hind limb ischemia. J Vasc Surg 67(6):1908–1920CrossRefPubMed
11.
12.
Zhang J, Xiao Z, Qu C, Cui W, Wang X, Du J (2014) CD8 T cells are involved in skeletal muscle regeneration through facilitating MCP-1 secretion and Gr1(high) macrophage infiltration. J Immunol 193(10):5149–5160CrossRefPubMed
13.
Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13.
14.
Fu X, Xiao J, Wei Y, Li S, Liu Y, Yin J, Sun K, Sun H, Wang H, Zhang Z, Zhang BT, Sheng C, Wang H, Hu P (2015) Combination of inflammation-related cytokines promotes long-term muscle stem cell expansion. Cell Res 25(6):655–673CrossRefPubMedPubMedCentral
15.
Hata T, Takahashi M, Hida S, Kawaguchi M, Kashima Y, Usui F, Morimoto H, Nishiyama A, Izawa A, Koyama J, Iwakura Y, Taki S, Ikeda U (2011) Critical role of Th17 cells in inflammation and neovascularization after ischaemia. Cardiovasc Res 90(2):364–372CrossRefPubMed
16.
Schiaffino S, Pereira MG, Ciciliot S, Rovere-Querini P (2017) Regulatory T cells and skeletal muscle regeneration. FEBS J 284(4):517–524CrossRefPubMed
17.
18.
19.
Nakaya M, Xiao Y, Zhou X, Chang JH, Chang M, Cheng X, Blonska M, Lin X, Sun SC (2014) Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40(5):692–705CrossRefPubMedPubMedCentral
20.
Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, Chmielewski K, Stewart KM, Ashall J, Everts B, Pearce EJ, Driggers EM, Artyomov MN (2015) Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42(3):419–430CrossRefPubMed
21.
Menge BA, Schrader H, Ritter PR, Ellrichmann M, Uhl W, Schmidt WE, Meier JJ (2010) Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes. Regul Pept 160(1–3):75–80CrossRefPubMed
22.
23.
Walker LS, von Herrath M (2016) CD4 T cell differentiation in type 1 diabetes. Clin Exp Immunol 183(1):16–29CrossRefPubMed
24.
Cucak H, Grunnet LG, Rosendahl A (2014) Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization. J Leukoc Biol 95(1):149–160CrossRefPubMed
25.
26.
Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H (1988) Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37(1):21–27CrossRefPubMed
27.
Ayala JE, Samuel VT, Morton GJ, Obici S, Croniger CM, Shulman GI, Wasserman DH, McGuinness OP, Consortium NIHMMPC (2010) Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 3(9–10):525–534
28.
Tsai PH, Yeh CL, Liu JJ, Chiu WC, Yeh SL (2012) Effects of dietary glutamine on inflammatory mediator gene expressions in rats with streptozotocin-induced diabetes. Nutrition 28(3):288–293CrossRefPubMed
29.
Tsai PH, Liu JJ, Yeh CL, Chiu WC, Yeh SL (2012) Effects of glutamine supplementation on oxidative stress-related gene expression and antioxidant properties in rats with streptozotocin-induced type 2 diabetes. Br J Nutr 107(8):1112–1118CrossRefPubMed
30.
Takeda K, Duan LJ, Takeda H, Fong GH (2014) Improved vascular survival and growth in the mouse model of hindlimb ischemia by a remote signaling mechanism. Am J Pathol 184(3):686–696CrossRefPubMedPubMedCentral
31.
Yan J, Tie G, Park B, Yan Y, Nowicki PT, Messina LM (2009) Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. J Vasc Surg 50(6):1412–1422CrossRefPubMedPubMedCentral
32.
Lozeron P, Mantsounga CS, Broqueres-You D, Dohan A, Polivka M, Deroide N, Silvestre JS, Kubis N, Lévy BI (2015) Characterization of nerve and microvessel damage and recovery in type 1 diabetic mice after permanent femoral artery ligation. J Neurosci Res 93(9):1451–1461CrossRefPubMed
33.
Su ST, Yeh CL, Hou YC, Pai MH, Yeh SL (2017) Dietary glutamine supplementation enhances endothelial progenitor cell mobilization in streptozotocin-induced diabetic mice subjected to limb ischemia. J Nutr Biochem 40:86–94CrossRefPubMed
34.
Hori K, Tsujii M, Iino T, Satonaka H, Uemura T, Akeda K, Hasegawa M, Uchida A, Sudo A (2013) Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb. BMC Musculoskelet Disord 14:113CrossRefPubMedPubMedCentral
35.
36.
Xiao W, Liu Y, Luo B, Zhao L, Liu X, Zeng Z, Chen P (2016) Time-dependent gene expression analysis after mouse skeletal muscle contusion. J Sport Health Sci 5(1):101–108CrossRefPubMedPubMedCentral
37.
Cui G, Qin X, Zhang Y, Gong Z, Ge B, Zang YQ (2009) Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. J Biol Chem 284(41):28420–28429CrossRefPubMedPubMedCentral
38.
Simon F, Oberhuber A, Floros N, Busch A, Wagenhauser MU, Schelzig H, Duran M (2018) Acute limb ischemia-much more than just a lack of oxygen. Int J Mol Sci 19(2):374CrossRefPubMedCentral
39.
Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, Brownlee M, Gurtner GC (2008) Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 283(16):10930–10938CrossRefPubMedPubMedCentral
40.
Alves WF, Aguiar EE, Guimaraes SB, da Silva Filho AR, Pinheiro PM, Soares Gdos S, de Vasconcelos PR (2010) L-alanyl-glutamine preoperative infusion in patients with critical limb ischemia subjected to distal revascularization reduces tissue damage and protects from oxidative stress. Ann Vasc Surg 24(4):461–467CrossRefPubMed
41.
Shih YM, Shih JM, Pai MH, Hou YC, Yeh CL, Yeh SL (2016) Glutamine administration after sublethal lower limb ischemia reduces inflammatory reaction and offers organ protection in ischemia/reperfusion injury. JPEN J Parenter Enteral Nutr 40(8):1122–1130CrossRefPubMed
42.
Börner C, Lanciotti S, Koch T, Höllt V, Kraus J (2013) μ opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes. J Neuroimmunol 263(1–2):35–42CrossRefPubMed
43.
44.
Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover L, Vizcay-Barrena G, Hedrick CC, Cook HT, Diebold S, Geissmann F (2013) Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 153(2):362–375CrossRefPubMedPubMedCentral
45.
Krieger JR, Ogle ME, McFaline-Figueroa J, Segar CE, Temenoff JS, Botchwey EA (2016) Spatially localized recruitment of anti-inflammatory monocytes by SDF-1alpha-releasing hydrogels enhances microvascular network remodeling. Biomaterials 77:280–290CrossRefPubMed
46.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133(5):775–787CrossRefPubMed
47.
Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, Sefik E, Tan TG, Wagers AJ, Benoist C, Mathis D (2013) A special population of regulatory T cells potentiates muscle repair. Cell 155(6):1282–1295CrossRefPubMedPubMedCentral
48.
Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178(4):2018–2027CrossRefPubMed
49.
Yaqoob P, Calder PC (1997) Glutamine requirement of proliferating T lymphocytes. Nutrition 13(7–8):646–651CrossRefPubMed
50.
Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG (2010) CCR51 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176(5):2177–2187CrossRefPubMedPubMedCentral
51.
Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, Piccirillo CA (2006) CCR52-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 203(11):2451–2460CrossRefPubMedPubMedCentral
52.
Weber C (2003) Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J Mol Med (Berl) 81(1):4–19CrossRef
53.
Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204(5):1057–1069CrossRefPubMedPubMedCentral
54.
Lu H, Huang D, Saederup N, Charo IF, Ransohoff RM, Zhou L (2011) Macrophages recruited via CCR55 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J 25(1):358–369CrossRefPubMedPubMedCentral
55.
56.
Zhou J, Liu B, Liang C, Li Y, Song YH (2016) Cytokine signaling in skeletal muscle wasting. Trends Endocrinol Metab 27(5):335–347CrossRefPubMed
57.
Chen SE, Jin B, Li YP (2007) TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 292(5):C1660–1671CrossRefPubMed
58.
Zhang C, Li Y, Wu Y, Wang L, Wang X, Du J (2013) Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem 288(3):1489–1499CrossRefPubMed
59.
Deng B, Wehling-Henricks M, Villalta SA, Wang Y, Tidball JG (2012) IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol 189(7):3669–3680CrossRefPubMed
60.
Gong D, Shi W, Yi SJ, Chen H, Groffen J, Heisterkamp N (2012) TGFbeta signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol 13:31CrossRefPubMedPubMedCentral
61.
Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, Schols AM (2009) PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab 297(1):E174–183CrossRefPubMed
62.
Metadata
Title
Effects of dietary glutamine supplementation on immune cell polarization and muscle regeneration in diabetic mice with limb ischemia
Authors
Man-Hui Pai
Cing-Syuan Lei
Shiau-Tsz Su
Sung-Ling Yeh
Yu-Chen Hou
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 3/2020
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-019-01951-4

Other articles of this Issue 3/2020

European Journal of Nutrition 3/2020 Go to the issue

Original Contribution

Higher protein intake is associated with a lower likelihood of frailty among older women, Kuopio OSTPRE-Fracture Prevention Study

Original Contribution

A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137)

Review

Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto’s thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies

Original Contribution

Ultra-processed food consumption and the incidence of depression in a Mediterranean cohort: the SUN Project

Original Contribution

High-fat diet promotes adrenaline production by visceral adipocytes

Review

Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits